DSG2 and central nervous system cancer: The improved infectivity of Ad5/3 chimeric fiber, which recognizes Ad3 receptors (CD46 and DSG2), was demonstrated in different cancer models, including breast cancer [51], glioma [52], esophageal adenocarcinoma [53], and pancreatic cancer [32,54].